Medical Weight Loss Treatment for Maine Residents
Medically Supervised Weight Loss, Delivered Online
OmniRx Health providers are licensed by the Maine Board of Licensure in Medicine to serve patients throughout the Pine Tree State.
Whether you're in Portland, Augusta, or anywhere across Maine — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Maine
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
Maine's rugged beauty extends from Portland's vibrant waterfront to the remote forests of Aroostook County. OmniRx Health serves this diverse landscape—connecting lobstermen on the coast, ski resort workers in the mountains, and retirees seeking the quiet life with expert medical care. Our telehealth platform eliminates the long drives that Maine's geography often requires, bringing healthcare as close as your living room in the Pine Tree State.
Available Treatments in Maine
Our board-certified providers in Maine can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Maine
State Licensing
OmniRx Health providers are licensed by the Maine Board of Licensure in Medicine to serve patients throughout the Pine Tree State.
Telehealth Law
Maine has progressive telehealth laws that address the unique needs of its rural and island communities, ensuring virtual care access statewide.
Pharmacy Access
Maine pharmacies in Portland, Bangor, Augusta, and coastal communities provide prescription services with delivery to all corners of the state.
Insurance Notes
Maine requires insurers to cover telehealth services at parity with in-person care, making virtual visits accessible and affordable.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Maine
Explore Related Medical Weight Loss Pages
Direct links to specific treatments and other states.